Cargando…
LECT2 Ameliorates Blood–Retinal Barrier Impairment Secondary to Diabetes Via Activation of the Tie2/Akt/mTOR Signaling Pathway
PURPOSE: Current treatments for diabetic retinopathy (DR) have considerable limitations, emphasizing the need for new therapeutic options. The effect of leukocyte cell-derived chemotaxin 2 (LECT2) on diabetes-induced blood–retinal barrier impairment and the possible underlying mechanism were investi...
Autores principales: | Qin, Yuan-Jun, Xiao, Ke, Zhong, Zheng, Zhao, Yin, Yu, Tian, Sun, Xu-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934553/ https://www.ncbi.nlm.nih.gov/pubmed/35262733 http://dx.doi.org/10.1167/iovs.63.3.7 |
Ejemplares similares
-
Progressive Choriocapillaris Impairment in ABCA4 Maculopathy Is Secondary to Retinal Pigment Epithelium Atrophy
por: Jauregui, Ruben, et al.
Publicado: (2020) -
Direct Tie2 Agonists Stabilize Vasculature for the Treatment of Diabetic Macular Edema
por: Agard, Nicholas J., et al.
Publicado: (2022) -
Low-Dose Trans-Resveratrol Ameliorates Diabetes-Induced Retinal Ganglion Cell Degeneration via TyrRS/c-Jun Pathway
por: Xiao, Ke, et al.
Publicado: (2023) -
Pathophysiology of Secondary Macular Hole in Rhegmatogenous Retinal Detachment
por: Martins Melo, Isabela, et al.
Publicado: (2023) -
Inhibition of mTOR via an AAV-Delivered shRNA Tested in a Rat OIR Model as a Potential Antiangiogenic Gene Therapy
por: Lee, Steven Hyun Seung, et al.
Publicado: (2020)